Partnering opportunities

Partnering opportunities

Hands with petri dish

The Institute has more than 300 research projects underway in cancer, immunology and infectious diseases, feeding into our discovery and development pipeline. We are committed to the translation of our discoveries into improvements in disease diagnosis, prevention and treatment.

Projects and reagents

Our portfolio of projects and reagents are available for licensing or collaboration:

  • Chemical and biological agents demonstrating proof-of-efficacy

  • Biomarkers

  • Drug targets

  • Monoclonal and polyclonal antibodies

  • Enabling technologies

Partnering opportunities now open

Project pipeline - available for partnering


Opportunities in cancer

Opportunities in immune health and inflammation

Opportunities in healthy development and ageing


To discuss partnering opportunities, please contact Dr Anne-Laure Puaux, Head of Commercialisation, by email